Cellectis Historical Cash Flow
| CLLS Stock | USD 2.13 0.01 0.47% |
Analysis of Cellectis cash flow over time is an excellent tool to project Cellectis SA future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Stock Based Compensation of 5 M or Begin Period Cash Flow of 164.8 M as it is a great indicator of Cellectis ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Cellectis SA latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cellectis SA is a good buy for the upcoming year.
Cellectis |
About Cellectis Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Cellectis balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Cellectis's non-liquid assets can be easily converted into cash.
Cellectis Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Change In Working Capital
The difference in the amount of working capital from one period to the next, indicating the change in a company's short-term assets and liabilities.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Depreciation
Depreciation indicates how much of Cellectis SA value has been used up. For tax purposes Cellectis can deduct the cost of the tangible assets it purchases as business expenses. However, Cellectis SA must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.Most accounts from Cellectis' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Cellectis SA current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cellectis SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. At this time, Cellectis' Change In Cash is comparatively stable compared to the past year. Begin Period Cash Flow is likely to gain to about 164.8 M in 2024, whereas Free Cash Flow is likely to drop (27.1 M) in 2024.
Cellectis cash flow statement Correlations
Click cells to compare fundamentals
Cellectis Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Cellectis cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (111.0M) | (99.4M) | (55.5M) | (92.4M) | 43.5M | 45.7M | |
| Stock Based Compensation | 26.9M | 10.0M | 11.5M | 6.0M | 5.2M | 5.0M | |
| Free Cash Flow | (82.1M) | (126.5M) | (124.3M) | (89.9M) | (25.8M) | (27.1M) | |
| Change In Working Capital | 11.7M | (21.8M) | (4.2M) | (5.7M) | (4.0M) | (3.8M) | |
| Begin Period Cash Flow | 451.5M | 340.5M | 241.1M | 185.6M | 93.2M | 164.8M | |
| Other Cashflows From Financing Activities | (3.9M) | (1.3M) | 13.5M | 8.3M | (9.6M) | (9.2M) | |
| Depreciation | 6.9M | 9.8M | 16.6M | 18.4M | 18.5M | 19.4M | |
| Other Non Cash Items | (8.3M) | 12.0M | (5.6M) | (7.6M) | 71.9M | 75.5M | |
| Capital Expenditures | 13.0M | 46.3M | 19.7M | 2.4M | 1.1M | 1.0M | |
| Total Cash From Operating Activities | (69.1M) | (80.3M) | (104.6M) | (87.4M) | (24.7M) | (26.0M) | |
| Net Income | (115.2M) | (97.5M) | (125.1M) | (98.7M) | (116.8M) | (111.0M) | |
| Total Cash From Financing Activities | (3.9M) | 27.3M | 47.5M | 1.1M | 82.9M | 56.2M | |
| End Period Cash Flow | 340.5M | 241.1M | 185.6M | 93.2M | 136.7M | 175.2M | |
| Sale Purchase Of Stock | 3.1M | 186.7M | (469K) | (569K) | (654.4K) | (621.6K) | |
| Change To Inventory | (37K) | (2.6M) | 1.3M | 1.6M | 1.7M | 0.0 | |
| Change To Account Receivables | (2.7M) | (8.3M) | (5.8M) | (3.2M) | 2.3M | 2.4M | |
| Investments | (35.9M) | (54.3M) | 27.0M | (2.8M) | (15.5M) | (14.7M) | |
| Net Borrowings | (3.4M) | 17.6M | (12.5M) | (6.6M) | (5.9M) | (5.6M) | |
| Total Cashflows From Investing Activities | (35.9M) | (54.3M) | 7.3M | (2.8M) | (2.5M) | (2.6M) | |
| Change To Operating Activities | 7.4M | (685K) | 654K | (5.8M) | (5.2M) | (5.0M) | |
| Change To Netincome | 14.4M | 12.8M | (2.8M) | 6.0M | 5.4M | 5.1M | |
| Change To Liabilities | 9.6M | (14.1M) | (583K) | 3.3M | 2.9M | 3.1M | |
| Issuance Of Capital Stock | (125K) | 9.2M | 48.5M | 13.2M | 67.9M | 50.0M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cellectis Stock Analysis
When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.